Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019

FDA Clears Advancements for Viewray MRIdian Radiation Therapy System

Enhancements include new soft tissue visualization capabilities, upgrades to reduce treatment delivery time

FDA Clears Advancements for Viewray MRIdian Radiation Therapy System

February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market new soft tissue visualization capabilities for its MRIdian image-guided radiation therapy (IGRT) system.

The new upgradable capabilities enhance the features of MRIdian's SmartVISION MRI (magnetic resonance imaging), including:

  • Expanded high-definition visualization and enhanced contrast between different tissues, to assist clinicians with tissue visualization and beam contouring;
  • The potential to aid in the assessment and prediction of tumor response to radiation therapy is enabled by "DWI", a diffusion weighted imaging feature that tracks treatment progress by distinguishing between tumor and normal tissues;
  • Faster, brighter, more detailed anatomical planar imaging to strike tumors with greater precision and accuracy through proprietary technology, which allows for a 2X increase in MRI speed (to 8 frames per second), a 2X increase in image resolution, and a 2X improvement in MR signal-to-noise ratio (SNR); and
  • Potential reduction in treatment delivery time through enhanced multileaf collimator (MLC) speed.

MRIdian's SmartVISION provides high-definition, diagnostic-quality MR imaging. SmartVISION was designed to maintain high-fidelity beam delivery while mitigating the risks of skin toxicities, as well as trapped or distorted dose. MRIdian's SmartADAPT helps allow clinicians to generate daily MR setup scans in seconds and leverage high-contrast anatomical detail to rapidly reshape dose delivery based on the current position of both the tumor and adjacent critical structures – all while the patient is in the treatment position. MRIdian's SmartTARGET visualizes the tumor's edges and surrounding organ position in real-time using a non-ionizing, streaming video perspective. When tumors or organs-at-risk change shape or position, SmartTARGET instantly reacts, automatically controlling beam delivery.

For more information: www.viewray.com

Related MRIdian Content

VIDEO: Clinical Use of the ViewRay MRIdian Linac System at Henry Ford

VIDEO: MRI-Guided Radiation Therapy Trial for Pancreatic Cancer

Related Content

 MRI system cardiac scan from DeBakey Hospital
News | Magnetic Resonance Imaging (MRI) | December 05, 2019
December 5, 2019 — The following is by Lawr
MRI Exablate neuro helmet from INSIGHTEC

MRI Exablate neuro helmet from INSIGHTEC. Image courtesy of Ali Rezai, M.D., and RSNA.

News | Clinical Trials | December 03, 2019
December 3, 2019 — Focused ultrasound is a safe and effective way to target and open areas of the blood-brain barrier
Reduction in fractional anisotropy (FA) in obese patients compared to the control group

Reduction in fractional anisotropy (FA) in obese patients compared to the control group: At the intersection of the alignment vectors, a large cluster of FA decrease located in the corpus callosum on the left. In red: Reduction of FA in obese patients compared to controls, and FA skeleton (green), superimposed on the mean of FA images in sample. Image courtesy of Pamela Bertolazzi, Ph.D., and RSNA.

News | Clinical Trials | November 25, 2019
November 25, 2019 — Researchers using magn...
Image by Volker Pietzonka from Pixabay

Image by Volker Pietzonka from Pixabay

News | Pediatric Imaging | November 25, 2019
November 25, 2019 — Connectivity in an area of the brain that regulates emotion may be altered in infants exposed to
Embrace Neonatal MRI is a U.S. Food and Drug Administration (FDA) cleared and CE marked compact magnetic resononance imaging (MRI) system ergonomically designed to fit inside the neonatal intensive care unit (NICU)
News | Magnetic Resonance Imaging (MRI) | November 25, 2019
November 25, 2019 — Embrace Neonatal MRI is a U.S.
FerrAlert technology automatically detects and logs ferromagnetic events and exclusively provides a photographic stream which is date and time stamped
News | Magnetic Resonance Imaging (MRI) | November 22, 2019
November 22, 2019 — Kopp Development Inc. acquired Mednovus, Inc.
One in three adults treated for cancer may experience side effects from treatment they wish they had known more about, according to a new survey published today in the Journal of Oncology Practice
News | Clinical Trials | November 21, 2019
November 21, 2019 — One in three adults treated for cancer may experience side effects from treatment they wish they
The study finds it's possible to use commercial facial recognition software to identify people from brain MRI that includes imagery of the face
News | Magnetic Resonance Imaging (MRI) | November 15, 2019
November 15, 2019 — Though identifying data typically are removed from medical image files before they are shared for